Bagnall Nigel Mark, Faiz Omar, Darzi Ara, Athanasiou Thanos
Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):398-402. doi: 10.1093/icvts/ivt197. Epub 2013 May 10.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether frailty scoring can be used either separately or combined with conventional risk scores to predict survival and complications. Five hundred and thirty-five papers were found using the reported search, of which nine cohort studies represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. There is a paucity of evidence, as advanced age is a criterion for exclusion in most randomized controlled trials. Conventional models of risk following cardiac surgery are not calibrated to accurately predict the outcomes in the elderly and do not currently include frailty parameters. There is no universally accepted definition for frailty, but it is described as a physiological decline in multiple organ systems, decreasing a patient's capacity to withstand the stresses of surgery and disease. Frailty is manifest clinically as deficits in functional capacity, such as slow ambulation and impairments in the activities of daily living (ADL). Analysis of predictive models using area under receiver operating curves (AUC) suggested only a modest benefit by adding gait speed to a Society of Thoracic Surgeons (STS score)-Predicted Risk of Mortality or Major Morbidity (PROM) risk score (AUC 0.04 mean difference). However, a specialist frailty assessment tool named FORECAST was found to be superior at predicting adverse outcomes at 1 year compared with either EuroSCORE or STS score (AUC 0.09 mean difference). However, risk models incorporating frailty parameters require further validation and have not been widely adopted. Routine collection of objective frailty measures such as 5-metre walk time and ADL assessment will help to provide data to develop new risk-assessment models to facilitate risk stratification and clinical decision-making in elderly patients. Based on the best evidence currently available, we conclude that frailty is an independent predictor of adverse outcome following cardiac surgery or transcatheter aortic valve implantation, increasing the risk of mortality 2- to 4-fold compared with non-frail patients.
一篇心脏外科的最佳证据主题文章是根据结构化方案撰写的。所探讨的问题是,衰弱评分是否可以单独使用,或者与传统风险评分相结合,来预测生存率和并发症。通过报告的检索方式共找到535篇论文,其中9项队列研究代表了回答该临床问题的最佳证据。这些论文的作者、期刊、发表日期和国家、所研究的患者群体、研究类型、相关结局和结果都被制成了表格。证据不足,因为在大多数随机对照试验中,高龄是排除标准。心脏手术后的传统风险模型未经过校准,无法准确预测老年人的结局,目前也未纳入衰弱参数。衰弱尚无普遍接受的定义,但它被描述为多个器官系统的生理衰退,降低了患者承受手术和疾病压力的能力。衰弱在临床上表现为功能能力缺陷,如行走缓慢和日常生活活动(ADL)受损。使用受试者操作特征曲线下面积(AUC)对预测模型进行分析表明,在胸外科医师协会(STS评分)预测的死亡风险或主要并发症(PROM)风险评分中加入步速,仅带来适度益处(AUC平均差异为0.04)。然而,与欧洲心脏手术风险评估系统(EuroSCORE)或STS评分相比,一种名为FORECAST的专业衰弱评估工具在预测1年不良结局方面更具优势(AUC平均差异为0.09)。然而,纳入衰弱参数的风险模型需要进一步验证,尚未得到广泛应用。常规收集客观的衰弱指标,如5米步行时间和ADL评估,将有助于提供数据以开发新的风险评估模型,从而便于对老年患者进行风险分层和临床决策。基于目前可得的最佳证据,我们得出结论,衰弱是心脏手术或经导管主动脉瓣植入术后不良结局的独立预测因素,与非衰弱患者相比,死亡风险增加2至4倍。